Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/
Accepted 2021-12-23 00:00:00 ET · period of report 2021-12-22 · accession 0001209191-21-071168 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-23 | 2021-12-22 | HRTX | Dissanaike Sharmila | Dir | A - Grant | $0.00 | +10.5K | 16.7K | +167% | $0 |
| D | 2021-12-23 | 2021-12-22 | HRTX | Dissanaike Sharmila | Dir | A - Grant | $0.00 | +20.9K | 20.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-22 | A | A | 10,452 | $0.00 | 16,702 | D | — | — | (F1) The shares were granted as restricted stock units which vest in full on December 22, 2022. |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-12-22 | A | A | 20,903 | $0.00 | 20,903 | D | $9.81 · — to 2031-12-22 | 20,903 Common Stock | (F2) The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant. |